Stemline. What is the latest??

it seems they have had some great internal house cleanings of recent.

What is the state of affairs?

 

Oncology company?

 

Fake news

 

It may have been fake news when you posted it, but it should be reality after today. Down 30% on their lowered guidance of under $12 MM- disappointing Q4 revenue.

The launch has been lackluster, over a year into it and we are looking at 40 patients a quarter? Looks like their salesforce strategy was not optimal for a rare disease drug. STML needed highly experienced hematology reps with a history of launching drugs that treat rare disorders. Not hematology indications with tens of thousands of patients or solid tumor, let alone supportive care experience.